Inari Medical to Announce Second Quarter 2022 Financial Results
July 18 2022 - 4:01PM
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device
company with a mission to treat and transform the lives of patients
suffering from venous and other diseases, announced today that it
will release its second quarter 2022 financial results on
Wednesday, August 3, 2022. In conjunction with the release, Inari
will host a conference call and webcast at 2:00 p.m. Pacific Time /
5:00 p.m. Eastern Time to discuss its financial results and recent
highlights.
To access the live call via telephone, please
register in advance using the link here. Upon registering, each
participant will receive an email confirmation with dial-in numbers
and a unique personal PIN that can be used to join the call.
The live webinar may be accessed by visiting the
Events Section of the Inari investor relations website at
ir.inarimedical.com. A replay of the webinar will be available
shortly after the conclusion of the call and will be archived on
Inari’s website.
About Inari Medical, Inc.
Inari Medical, Inc. is a medical device company with a mission
to treat and transform the lives of patients suffering from venous
and other diseases. Inari’s current product offering consists of
two minimally invasive, novel catheter-based mechanical
thrombectomy devices that are designed to remove large clots from
large vessels and eliminate the need for thrombolytic drugs. The
company purpose-built its products for the specific characteristics
of the venous system and the treatment of the two distinct
manifestations of venous thromboembolism, or VTE: deep vein
thrombosis and pulmonary embolism. The ClotTriever system is
510(k)-cleared by FDA and CE marked for the non-surgical removal of
clot from peripheral blood vessels, including for the use in the
treatment of deep vein thrombosis. The FlowTriever system is
510(k)-cleared by FDA and CE marked for the non-surgical removal of
clot from peripheral blood vessels, including for the use in the
treatment of pulmonary embolism and clot in transit in the right
atrium.
Investor Contact:ICR WestwickeCaroline
CornerPhone +1-415-202-5678 caroline.corner@westwicke.com
Inari Medical (NASDAQ:NARI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inari Medical (NASDAQ:NARI)
Historical Stock Chart
From Apr 2023 to Apr 2024